Insulin aspart, recombinant Subcutaneous and Qudexy XR
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Qudexy XR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: topiramate
Brand name: Qudexy XR Sprinkle, Topamax, Topamax Sprinkle, Trokendi XR, Qudexy XR, Topiragen
Synonyms: Qudexy XR Sprinkle, Qudexy XR Capsules
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Qudexy XR Capsules
- Insulin aspart, recombinant Subcutaneous-Qudexy XR Sprinkle
- Insulin aspart, recombinant Subcutaneous-Quelicin
- Insulin aspart, recombinant Subcutaneous-Quenalin
- Insulin aspart, recombinant Subcutaneous-Quenalog Topical
- Insulin aspart, recombinant Subcutaneous-Questran
- Qudexy XR-Insulin degludec
- Qudexy XR-Insulin Degludec (U-100) Prefilled Pens
- Qudexy XR-Insulin Degludec (U-100) Vials
- Qudexy XR-Insulin Degludec (U-200) Prefilled Pens
- Qudexy XR-Insulin degludec and liraglutide
- Qudexy XR-Insulin degludec and liraglutide Subcutaneous